Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | IFNA17 |
| Upstream (Parents) |
|---|
| (<<) LOC222070 → IFNA17 |
| Downstream (Children) |
|---|
| IFNA17 → IFNA21 (>>) |
| IFNA17 → ACSM3 (>>) |
| IFNA17 → RPS6KA6 (>>) |
| IFNA17 → OR5I1 (>>) |
| IFNA17 → SLCO1A2 (>>) |
| IFNA17 → MAGEA8 (>>) |
| IFNA17 → OR12D3 (>>) |
| IFNA17 → DZIP3 (>>) |
| IFNA17 → MRPS11P1 (>>) |
| IFNA17 → LILRP2 (>>) |
| IFNA17 → GPR98 (>>) |
| IFNA17 → SEL1L (>>) |
| IFNA17 → GRM3 (>>) |
| IFNA17 → GPA33 (>>) |
| IFNA17 → ST3GAL5 (>>) |
| IFNA17 → KDM5D (>>) |
| IFNA17 → GSG1 (>>) |
| IFNA17 → CIITA (>>) |
| IFNA17 → PLAC1 (>>) |
| IFNA17 → DRP2 (>>) |
| IFNA17 → FN3K (>>) |
| IFNA17 → DOK3 (>>) |
| IFNA17 → PRPS1L1 (>>) |
| IFNA17 → MSH4 (>>) |
| IFNA17 → GCNT4 (>>) |
| IFNA17 → NLE1 (>>) |
| IFNA17 → ZNF484 (>>) |
| IFNA17 → PIK3C3 (>>) |
| IFNA17 → PRL (>>) |
| IFNA17 → ASB6 (>>) |
| IFNA17 → MMP24 (>>) |
| IFNA17 → MOSC1 (>>) |
| IFNA17 → NKX2-1 (>>) |
| IFNA17 → GAGE3 (>>) |
| IFNA17 → LOC100093698 (>>) |
| IFNA17 → UTP18 (>>) |
| IFNA17 → NCAPH2 (>>) |
| IFNA17 → CDKN2C (>>) |
| IFNA17 → FEZ1 (>>) |
| IFNA17 → ODF1 (>>) |
| IFNA17 → AFF1 (>>) |
| IFNA17 → HTR3A (>>) |
| IFNA17 → OR2B2 (>>) |
| IFNA17 → ATP1A3 (>>) |
| IFNA17 → SERPINA4 (>>) |
| IFNA17 → KIR3DL3 (>>) |
| IFNA17 → PRY2///PRY (>>) |
| IFNA17 → S100A13 (>>) |
| IFNA17 → ADAM21P1///ADAM21 (>>) |
| IFNA17 → KLK6 (>>) |
| IFNA17 → PHF20 (>>) |
| IFNA17 → GNPTAB (>>) |
| IFNA17 → TMEM206 (>>) |
| IFNA17 → TSSK1B///TSSK1A (>>) |
